Logo image of VENU

VENU HOLDING CORP (VENU) Stock Fundamental Analysis

NYSEARCA:VENU - NYSE Arca - US92333E1047 - Common Stock - Currency: USD

12.94  +0.44 (+3.52%)

Fundamental Rating

3

Taking everything into account, VENU scores 3 out of 10 in our fundamental rating. VENU was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. VENU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VENU has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VENU had negative earnings in the past year.
VENU had a negative operating cash flow in the past year.
VENU Yearly Net Income VS EBIT VS OCF VS FCFVENU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of VENU (-15.41%) is worse than 87.79% of its industry peers.
With a Return On Equity value of -41.86%, VENU is not doing good in the industry: 63.36% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROIC N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VENU Yearly ROA, ROE, ROICVENU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

VENU's Gross Margin of 46.51% is in line compared to the rest of the industry. VENU outperforms 48.09% of its industry peers.
VENU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VENU Yearly Profit, Operating, Gross MarginsVENU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

VENU does not have a ROIC to compare to the WACC, probably because it is not profitable.
VENU has more shares outstanding than it did 1 year ago.
VENU has a worse debt/assets ratio than last year.
VENU Yearly Shares OutstandingVENU Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
VENU Yearly Total Debt VS Total AssetsVENU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that VENU is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.32, VENU perfoms like the industry average, outperforming 41.22% of the companies in the same industry.
VENU has a Debt/Equity ratio of 0.69. This is a neutral value indicating VENU is somewhat dependend on debt financing.
VENU has a Debt to Equity ratio of 0.69. This is in the better half of the industry: VENU outperforms 65.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC9.05%
VENU Yearly LT Debt VS Equity VS FCFVENU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 2.72 indicates that VENU has no problem at all paying its short term obligations.
VENU has a better Current ratio (2.72) than 93.89% of its industry peers.
A Quick Ratio of 2.70 indicates that VENU has no problem at all paying its short term obligations.
VENU's Quick ratio of 2.70 is amongst the best of the industry. VENU outperforms 93.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.7
VENU Yearly Current Assets VS Current LiabilitesVENU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for VENU have decreased strongly by -186.29% in the last year.
VENU shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.57%.
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

The Earnings Per Share is expected to grow by 114.33% on average over the next years. This is a very strong growth
Based on estimates for the next years, VENU will show a very strong growth in Revenue. The Revenue will grow by 225.43% on average per year.
EPS Next Y170.31%
EPS Next 2Y114.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year102.82%
Revenue Next 2Y225.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VENU Yearly Revenue VS EstimatesVENU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 50M 100M 150M
VENU Yearly EPS VS EstimatesVENU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

VENU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 7.64, the valuation of VENU can be described as very cheap.
Based on the Price/Forward Earnings ratio, VENU is valued cheaply inside the industry as 95.42% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, VENU is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.64
VENU Price Earnings VS Forward Price EarningsVENU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VENU Per share dataVENU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VENU's earnings are expected to grow with 114.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VENU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENU HOLDING CORP

NYSEARCA:VENU (7/21/2025, 8:04:00 PM)

12.94

+0.44 (+3.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)N/A N/A
Inst Owners3.14%
Inst Owner Change-0.74%
Ins Owners27.17%
Ins Owner Change-1.03%
Market Cap485.51M
Analysts82.22
Price Target14.45 (11.67%)
Short Float %0.97%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)-5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-28.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.64
P/S 27.91
P/FCF N/A
P/OCF N/A
P/B 6.2
P/tB 6.21
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)1.69
Fwd EY13.09%
FCF(TTM)-2.35
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.46
BVpS2.09
TBVpS2.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.51%
FCFM N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1934.1%
Cap/Sales 492.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.7
Altman-Z 1.32
F-Score2
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)1444.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)249.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
EPS Next Y170.31%
EPS Next 2Y114.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next Year102.82%
Revenue Next 2Y225.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.06%
OCF growth 3YN/A
OCF growth 5YN/A